HCM
NEO icon

Highlander Capital Management’s NeoGenomics NEO Stock Holding History

Highlander Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,000
Closed -$28K – 845
2015
Q3 		$28K Buy
+5,000
New +$31K 0.03% 476

Other funds holding NEO

GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Highlander Capital Management's NEO Position: Q4 2015 in Review

Highlander Capital Management sold out of NeoGenomics (NEO) in Q4 2015, closing a stake of 5,000 shares — an estimated $28K sold.

Highlander Capital Management first reported a position in NEO in Q3 2015 and held it in 1 quarter. The position peaked at $28K in Q3 2015. 119 funds tracked by Wall St. Rank hold NEO as of Q4 2015.

  • Highlander Capital Management reported no remaining NeoGenomics position as of Q4 2015 after selling out during the quarter.
  • Highlander Capital Management sold 5,000 NeoGenomics shares in Q4 2015, an estimated $28K.
  • Highlander Capital Management first reported a position in NeoGenomics in Q3 2015 and held it in 1 quarter.
  • Highlander Capital Management's NeoGenomics position peaked at $28K in Q3 2015.
  • 119 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2015.

Based on Highlander Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.